AstraZeneca - Oncology Pipeline AstraZeneca - Oncology Pipeline
  • Home
  • Tumor Type
  • Cell Pathway
  • Scientific Pillars
  • Glossary

BACK

Breast

Select areas under investigation to view related trials

View all Breast Trials
  • BRCAm or PALB2m breast cancer
  • HER2-positive breast cancer
  • HER2 IHC 0 metastatic breast cancer
  • HER2-low breast cancer
  • HR-positive/HER2-negative breast cancer
  • TNBC

Some compounds herein refer to selected AstraZeneca pipeline products still under development. AstraZeneca pipeline products are investigational products and, as such, are not approved by the US Food & Drug Administration (FDA), the European Medicines Agency (EMA) or any other regulatory agency for the uses under investigation. Information regarding these investigational products should, under no circumstances, be regarded as a recommendation for their use or of their safety or efficacy.

This site is intended for US Healthcare Professionals.

Veeva ID: Z4-80919 US-109129 DE-92568 Last Updated April 20263/26
©2026 AstraZeneca. All rights reserved.

  • Privacy Notice
  • |
  • Legal Terms of Use
  • |
  • Cookie Notice
  • Cookie Notice
  • |
  • Contact Us
  • Contact Us